NCT02928640View on ClinicalTrials.gov

ClariCore Optical Biopsy System Used in TRUS (Trans-Rectal Ultrasound)-Guided Prostrate Biopsy

NAUnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

January 31, 2020

Study Completion Date

December 31, 2020

Conditions
Cellular Diagnosis, Prostate Cancer
Interventions
DEVICE

ClariCore System

Data collection to build the prostrate tissue classification algorithm.

Trial Locations (5)

13210

Associated Professionals of New York, PLLC, Syracuse

21287

Johns Hopkins Brady Urological Institute- The Johns Hopkins Hospital, Baltimore

29572

Carolina Urologic Research Center, Myrtle Beach

48073

Comprehensive Urology, Royal Oak

80211

The Urology Center of Colorado, Denver

Sponsors
All Listed Sponsors
lead

Precision Biopsy, Inc.

INDUSTRY

NCT02928640 - ClariCore Optical Biopsy System Used in TRUS (Trans-Rectal Ultrasound)-Guided Prostrate Biopsy | Biotech Hunter | Biotech Hunter